Could AI help avoid unpredictable and high placebo response rates in pain trials?

Chronic pain researchers face significant data quality challenges resulting from subjective measures, retrospective data collection, and high placebo response rates. AI has potential to address many of these issues, but how can it be used safely and responsibly in future clinical trials?